Editor-in-Chief
Richard V. Levy, PhD
Dr. Levy became the ninth Editor-in-Chief of PDA Journal of Pharmaceutical Science and Technology in June 2018. Prior to that, he served as PDA's Senior Vice President of Scientific and Regulatory Affairs. In this capacity, he was responsible for directing and managing the scientific, technical, regulatory affairs, and quality activities at PDA. He was also responsible for the Association publications: PDA JPST, PDA technical reports and research surveys, and PDA Letter. Dr. Levy’s other key activities included working with PDA members to prepare and write consensus positions on proposed international regulations and guidance documents, and developing the scientific content of PDA’s global meetings and forums.
Prior to joining PDA, Dr. Levy was Corporate Vice President and General Manager of Parexel Consulting. Prior to joining Parexel Consulting, Dr. Levy was with Millipore Corporation (now MilliporeSigma) for 16 years in a variety of business, R&D, regulatory, and quality systems senior management positions. He was Chair-elect of the PDA Board of Directors (2004-2005) and served on that Board from 1999-2005.
Dr. Levy received his B.A. in Biology from Colby College (Waterville, ME) and an M.A. in Biology from Clark University (Worcester, MA). He received his Ph.D. in Environmental Health Sciences from Worcester Polytechnic Institute (Worcester, MA).
Associate Editors
Tony Cundell, PhD, Microbiological Consulting, LLC
Shanker Gupta, PhD, U.S. National Institutes of Health
Editorial Board
| James Akers, PhD, Consultant |  Jose Caraballo, MBA/ME, Kite, a Gilead Company |
 Dayue Chen, PhD, Genentech |
H. Gregg Claycamp, PhD, Independent Consultant |
 Tony Cundell, PhD, Microbiological Consulting, LLC |
 Fenton Fong, Msc, xCellarate Technology Consulting Inc. |
| Shanker Gupta, PhD, U.S. National Institutes of Health |
 Ankur Kulshrestha, PhD, Bristol Myers Squibb |
 Kelvin Lee, PhD, NIIMBL |
 Duncan Low, PhD, Claymore Biopharm LLC |
H anns-Christian Mahler, PhD, ten23 health AG |
Neha Pardeshi, PhD, Amgen |
| Wendy R. Saffell-Clemmer, MS, Baxter International Inc. |  Tim Sandle, PhD, Bio Products Laboratory Limited |
 Alicja Sobantka , PhD, Octapharma |
 István Szikora, MBA/MS, Novartis |
 Edward C. Tidswell, PhD, Merck |
 Henrietta Vinnerås, MSc, Fresenius Kabi AB |
 Kelly Waldron, PhD, ValSource |
 Wesley Workman, PhD, Workman Biotech Consultants LLC |
| Glenn Wright, PDA |  Earl Zablackis, PhD, Sanofi Pasteur |
 Steve Zdravkovic, BS, Baxter International Inc. |
 Qingyu Zeng, PhD, West Pharmaceutical Services |
|
Daniele Zuccato, MS, SCHOTT AG
|
PDA, Inc., Leadership
Chair
Jette Christensen, PhD, Novo Nordisk
Chair-elect
Susan Schniepp, Regulatory Compliance Associates Inc.
Treasurer
Melissa Seymour, Biogen, Inc.
Secretary
Emma Ramnarine, Roche Pharma
Immediate Past Chair
Rebecca Devine, PhD, Regulatory Consultant
Directors
Barbara Allen, PhD, Eli Lilly & Company
Michael Blackton, Adaptimmune, LLC
Bettine Boltres, West PharmaceuticalServices
Tia Bush, Amgen, Inc.
Javier Camposano, Celltrion
Ghada Haddad, PhD, Merck & Co., Inc./Merck Sharp & Dohme
Joyce Hansen, MBA, Johnson & Johnson
Stephan Krause, PhD, AstraZeneca Diagnostics
Mary Oates, PhD, Pfizer
Mathias Romacker, Pfizer (ret.)
Anil Sawant, PhD, Merck & Co., Inc./Merck Sharp & Dohme
Osamu Shirokizawa, Lifescienta
PDA Staff Liaisons
Richard Johnson, President & CEO
Walter Morris, Sr. Director, Publishing